Funded Tech Companies
AveXis
AveXis is a biopharmaceutical tech venture, based in Bannockburn. Venture investment and financing was provided by Roche Venture Fund, Adage Capital Management and Tavistock Life Sciences.
Company Overview
Company Name
AveXis
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2275 Half Day Rd. 200
Bannockburn, IL 60015
USA
Bannockburn, IL 60015
USA
Phone
Website
Email Address
Company Background Information
Overview
AveXis is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases, like spinal muscular atrophy (SMA).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/10/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Nolan
Chief Financial Officer
Phillip Donenberg
Chief Medical Officer
Sukumar Nagendran
Chief Scientific Officer
Allan Kaspar
VP - Bus. Development
Rick Modi
VP - Bus. Development
RA Session
VP - General Counsel
Michael Johannesen
VP - Human Resources
Lori Smith
VP - Manufacturing
Andrew Knudten
VP - Regulatory Affairs
James L'Italien
Company Investors
- Roche Venture Fund (Carole Nuechterlein)
- Adage Capital Management
- Tavistock Life Sciences
- Deerfield Capital (Jonathan Leff)
- Venrock (Bong Koh)
- Rock Springs Capital
- Foresite Capital
- RA Capital
- QVT Fund
- T. Rowe Price (Taymour Tamaddon)
- Janus Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs